Identifying novel biomarkers through data mining-a realistic scenario?
- PMID: 25347964
- PMCID: PMC4833187
- DOI: 10.1002/prca.201400107
Identifying novel biomarkers through data mining-a realistic scenario?
Abstract
In this article we discuss the requirements to use data mining of published proteomics datasets to assist proteomics-based biomarker discovery, the use of external data integration to solve the issue of inadequate small sample sizes and finally, we try to estimate the probability that new biomarkers will be identified through data mining alone.
Keywords: Bioinformatics; Biomarker; Data mining; Databases; Mass spectrometry.
© 2014 The Authors. PROTEOMICS - Clinical Applications Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures


References
-
- Cancer: the revolution has begun. Lancet 2010, 376, 1117. - PubMed
-
- Baselga, J. , Norton, L. , Albanell, J. , Kim, Y. M. , Mendelsohn, J. , Recombinant humanized anti‐HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 1998, 58, 2825–2831. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources